Exosome Pioneer Evox's Series B Gives It Needed Financial Runway, CEO Says
Privately held Evox Therapeutics raised £35.5m ($45.4m) of new capital in a series B financing round, adding to the £10m injected by a series A seed financing a year ago.
Privately held Evox Therapeutics raised £35.5m ($45.4m) of new capital in a series B financing round, adding to the £10m injected by a series A seed financing a year ago.